nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1H—smooth muscle tissue—colon cancer	0.00578	0.0849	CbGeAlD
Isradipine—Acute coronary syndrome—Irinotecan—colon cancer	0.00506	0.00555	CcSEcCtD
Isradipine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00504	0.00552	CcSEcCtD
Isradipine—Myocardial infarction—Irinotecan—colon cancer	0.00504	0.00551	CcSEcCtD
Isradipine—CACNA2D2—vagina—colon cancer	0.00497	0.073	CbGeAlD
Isradipine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00485	0.00531	CcSEcCtD
Isradipine—Myocardial infarction—Fluorouracil—colon cancer	0.00482	0.00528	CcSEcCtD
Isradipine—Libido decreased—Capecitabine—colon cancer	0.00481	0.00527	CcSEcCtD
Isradipine—Hypoaesthesia—Vincristine—colon cancer	0.00471	0.00516	CcSEcCtD
Isradipine—Atrial fibrillation—Capecitabine—colon cancer	0.00471	0.00516	CcSEcCtD
Isradipine—Bradycardia—Irinotecan—colon cancer	0.00469	0.00514	CcSEcCtD
Isradipine—Urinary tract disorder—Vincristine—colon cancer	0.00468	0.00512	CcSEcCtD
Isradipine—Connective tissue disorder—Vincristine—colon cancer	0.00465	0.0051	CcSEcCtD
Isradipine—Urethral disorder—Vincristine—colon cancer	0.00464	0.00508	CcSEcCtD
Isradipine—Cardiac failure—Capecitabine—colon cancer	0.00457	0.00501	CcSEcCtD
Isradipine—Cerebrovascular accident—Capecitabine—colon cancer	0.00455	0.00499	CcSEcCtD
Isradipine—Lethargy—Capecitabine—colon cancer	0.00455	0.00499	CcSEcCtD
Isradipine—Connective tissue disorder—Irinotecan—colon cancer	0.00453	0.00496	CcSEcCtD
Isradipine—Pain in extremity—Capecitabine—colon cancer	0.00446	0.00489	CcSEcCtD
Isradipine—Visual impairment—Irinotecan—colon cancer	0.00444	0.00487	CcSEcCtD
Isradipine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00443	0.00485	CcSEcCtD
Isradipine—CACNA1C—smooth muscle tissue—colon cancer	0.0044	0.0647	CbGeAlD
Isradipine—Cardiac disorder—Vincristine—colon cancer	0.00439	0.00481	CcSEcCtD
Isradipine—Hypoaesthesia—Fluorouracil—colon cancer	0.00439	0.00481	CcSEcCtD
Isradipine—CACNB2—digestive system—colon cancer	0.00431	0.0633	CbGeAlD
Isradipine—Angiopathy—Vincristine—colon cancer	0.0043	0.0047	CcSEcCtD
Isradipine—Flushing—Irinotecan—colon cancer	0.00428	0.00469	CcSEcCtD
Isradipine—Cardiac disorder—Irinotecan—colon cancer	0.00428	0.00469	CcSEcCtD
Isradipine—Mediastinal disorder—Vincristine—colon cancer	0.00427	0.00467	CcSEcCtD
Isradipine—Angiopathy—Irinotecan—colon cancer	0.00418	0.00458	CcSEcCtD
Isradipine—Immune system disorder—Irinotecan—colon cancer	0.00417	0.00456	CcSEcCtD
Isradipine—Mediastinal disorder—Irinotecan—colon cancer	0.00416	0.00455	CcSEcCtD
Isradipine—Mental disorder—Vincristine—colon cancer	0.00415	0.00454	CcSEcCtD
Isradipine—Urine output increased—Methotrexate—colon cancer	0.00414	0.00453	CcSEcCtD
Isradipine—Liver function test abnormal—Capecitabine—colon cancer	0.00412	0.00451	CcSEcCtD
Isradipine—Gynaecomastia—Methotrexate—colon cancer	0.00409	0.00448	CcSEcCtD
Isradipine—Breast disorder—Capecitabine—colon cancer	0.00403	0.00442	CcSEcCtD
Isradipine—Back pain—Vincristine—colon cancer	0.00399	0.00437	CcSEcCtD
Isradipine—Back pain—Irinotecan—colon cancer	0.00388	0.00425	CcSEcCtD
Isradipine—Muscle spasms—Irinotecan—colon cancer	0.00386	0.00423	CcSEcCtD
Isradipine—Nisoldipine—ABCB1—colon cancer	0.00381	0.203	CrCbGaD
Isradipine—Anaemia—Vincristine—colon cancer	0.00381	0.00417	CcSEcCtD
Isradipine—CACNB2—vagina—colon cancer	0.00381	0.0559	CbGeAlD
Isradipine—Polyuria—Methotrexate—colon cancer	0.00378	0.00414	CcSEcCtD
Isradipine—Angina pectoris—Capecitabine—colon cancer	0.00376	0.00411	CcSEcCtD
Isradipine—CACNA2D1—bone marrow—colon cancer	0.00373	0.0548	CbGeAlD
Isradipine—Ill-defined disorder—Irinotecan—colon cancer	0.00372	0.00408	CcSEcCtD
Isradipine—Anaemia—Irinotecan—colon cancer	0.00371	0.00406	CcSEcCtD
Isradipine—Abdominal discomfort—Capecitabine—colon cancer	0.0037	0.00405	CcSEcCtD
Isradipine—Leukopenia—Vincristine—colon cancer	0.00369	0.00404	CcSEcCtD
Isradipine—Vision blurred—Fluorouracil—colon cancer	0.00362	0.00397	CcSEcCtD
Isradipine—Malaise—Irinotecan—colon cancer	0.00362	0.00396	CcSEcCtD
Isradipine—Syncope—Irinotecan—colon cancer	0.0036	0.00394	CcSEcCtD
Isradipine—Leukopenia—Irinotecan—colon cancer	0.00359	0.00394	CcSEcCtD
Isradipine—CACNA2D1—vagina—colon cancer	0.00357	0.0525	CbGeAlD
Isradipine—Nitrendipine—ABCB1—colon cancer	0.00356	0.19	CrCbGaD
Isradipine—Anaemia—Fluorouracil—colon cancer	0.00355	0.00389	CcSEcCtD
Isradipine—Loss of consciousness—Irinotecan—colon cancer	0.00353	0.00386	CcSEcCtD
Isradipine—Photosensitivity reaction—Capecitabine—colon cancer	0.00352	0.00385	CcSEcCtD
Isradipine—Weight increased—Capecitabine—colon cancer	0.00351	0.00384	CcSEcCtD
Isradipine—Visual disturbance—Methotrexate—colon cancer	0.0035	0.00384	CcSEcCtD
Isradipine—Cough—Irinotecan—colon cancer	0.0035	0.00384	CcSEcCtD
Isradipine—CACNA1C—digestive system—colon cancer	0.00348	0.0511	CbGeAlD
Isradipine—Leukopenia—Fluorouracil—colon cancer	0.00344	0.00377	CcSEcCtD
Isradipine—Depression—Capecitabine—colon cancer	0.00343	0.00375	CcSEcCtD
Isradipine—CACNA1H—liver—colon cancer	0.0034	0.0499	CbGeAlD
Isradipine—Acute coronary syndrome—Capecitabine—colon cancer	0.00339	0.00371	CcSEcCtD
Isradipine—Cerebrovascular accident—Methotrexate—colon cancer	0.00339	0.00371	CcSEcCtD
Isradipine—Lethargy—Methotrexate—colon cancer	0.00339	0.00371	CcSEcCtD
Isradipine—Discomfort—Irinotecan—colon cancer	0.00338	0.0037	CcSEcCtD
Isradipine—Myocardial infarction—Capecitabine—colon cancer	0.00337	0.00369	CcSEcCtD
Isradipine—Anaphylactic shock—Vincristine—colon cancer	0.00336	0.00368	CcSEcCtD
Isradipine—Oedema—Vincristine—colon cancer	0.00336	0.00368	CcSEcCtD
Isradipine—Nervous system disorder—Vincristine—colon cancer	0.0033	0.00361	CcSEcCtD
Isradipine—Thrombocytopenia—Vincristine—colon cancer	0.00329	0.00361	CcSEcCtD
Isradipine—Oedema—Irinotecan—colon cancer	0.00328	0.00359	CcSEcCtD
Isradipine—Anaphylactic shock—Irinotecan—colon cancer	0.00328	0.00359	CcSEcCtD
Isradipine—Chest pain—Fluorouracil—colon cancer	0.00327	0.00358	CcSEcCtD
Isradipine—Hyperhidrosis—Vincristine—colon cancer	0.00325	0.00356	CcSEcCtD
Isradipine—Hepatobiliary disease—Capecitabine—colon cancer	0.00325	0.00356	CcSEcCtD
Isradipine—Discomfort—Fluorouracil—colon cancer	0.00323	0.00354	CcSEcCtD
Isradipine—Shock—Irinotecan—colon cancer	0.00322	0.00353	CcSEcCtD
Isradipine—CACNA2D2—lymph node—colon cancer	0.00321	0.0472	CbGeAlD
Isradipine—Nervous system disorder—Irinotecan—colon cancer	0.00321	0.00352	CcSEcCtD
Isradipine—CACNB2—liver—colon cancer	0.00321	0.0471	CbGeAlD
Isradipine—Thrombocytopenia—Irinotecan—colon cancer	0.00321	0.00351	CcSEcCtD
Isradipine—Hyperhidrosis—Irinotecan—colon cancer	0.00317	0.00347	CcSEcCtD
Isradipine—Hypotension—Vincristine—colon cancer	0.00314	0.00344	CcSEcCtD
Isradipine—Bradycardia—Capecitabine—colon cancer	0.00314	0.00344	CcSEcCtD
Isradipine—Anaphylactic shock—Fluorouracil—colon cancer	0.00314	0.00344	CcSEcCtD
Isradipine—Oedema—Fluorouracil—colon cancer	0.00314	0.00344	CcSEcCtD
Isradipine—Hepatitis—Capecitabine—colon cancer	0.00309	0.00338	CcSEcCtD
Isradipine—Nervous system disorder—Fluorouracil—colon cancer	0.00308	0.00337	CcSEcCtD
Isradipine—Thrombocytopenia—Fluorouracil—colon cancer	0.00307	0.00336	CcSEcCtD
Isradipine—CACNA1C—vagina—colon cancer	0.00307	0.0451	CbGeAlD
Isradipine—Hypoaesthesia—Capecitabine—colon cancer	0.00307	0.00336	CcSEcCtD
Isradipine—Amlodipine—ABCB1—colon cancer	0.00307	0.164	CrCbGaD
Isradipine—Liver function test abnormal—Methotrexate—colon cancer	0.00307	0.00336	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00307	0.00336	CcSEcCtD
Isradipine—Tachycardia—Fluorouracil—colon cancer	0.00306	0.00335	CcSEcCtD
Isradipine—Hypotension—Irinotecan—colon cancer	0.00306	0.00335	CcSEcCtD
Isradipine—Urinary tract disorder—Capecitabine—colon cancer	0.00305	0.00334	CcSEcCtD
Isradipine—Insomnia—Vincristine—colon cancer	0.00304	0.00333	CcSEcCtD
Isradipine—Oedema peripheral—Capecitabine—colon cancer	0.00304	0.00333	CcSEcCtD
Isradipine—Connective tissue disorder—Capecitabine—colon cancer	0.00303	0.00332	CcSEcCtD
Isradipine—Urethral disorder—Capecitabine—colon cancer	0.00303	0.00331	CcSEcCtD
Isradipine—Paraesthesia—Vincristine—colon cancer	0.00302	0.00331	CcSEcCtD
Isradipine—CACNA2D1—liver—colon cancer	0.00302	0.0443	CbGeAlD
Isradipine—Breast disorder—Methotrexate—colon cancer	0.003	0.00329	CcSEcCtD
Isradipine—Visual impairment—Capecitabine—colon cancer	0.00297	0.00326	CcSEcCtD
Isradipine—Insomnia—Irinotecan—colon cancer	0.00296	0.00325	CcSEcCtD
Isradipine—Paraesthesia—Irinotecan—colon cancer	0.00294	0.00322	CcSEcCtD
Isradipine—Hypotension—Fluorouracil—colon cancer	0.00293	0.00321	CcSEcCtD
Isradipine—Decreased appetite—Vincristine—colon cancer	0.00292	0.0032	CcSEcCtD
Isradipine—Dyspnoea—Irinotecan—colon cancer	0.00292	0.0032	CcSEcCtD
Isradipine—Somnolence—Irinotecan—colon cancer	0.00291	0.00319	CcSEcCtD
Isradipine—Gastrointestinal disorder—Vincristine—colon cancer	0.0029	0.00318	CcSEcCtD
Isradipine—Fatigue—Vincristine—colon cancer	0.0029	0.00318	CcSEcCtD
Isradipine—Eye disorder—Capecitabine—colon cancer	0.00288	0.00316	CcSEcCtD
Isradipine—Dyspepsia—Irinotecan—colon cancer	0.00288	0.00316	CcSEcCtD
Isradipine—Constipation—Vincristine—colon cancer	0.00288	0.00315	CcSEcCtD
Isradipine—Flushing—Capecitabine—colon cancer	0.00286	0.00314	CcSEcCtD
Isradipine—Cardiac disorder—Capecitabine—colon cancer	0.00286	0.00314	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00286	0.00313	CcSEcCtD
Isradipine—Decreased appetite—Irinotecan—colon cancer	0.00285	0.00312	CcSEcCtD
Isradipine—Insomnia—Fluorouracil—colon cancer	0.00284	0.00311	CcSEcCtD
Isradipine—Felodipine—ABCB1—colon cancer	0.00284	0.152	CrCbGaD
Isradipine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00283	0.0031	CcSEcCtD
Isradipine—Fatigue—Irinotecan—colon cancer	0.00282	0.00309	CcSEcCtD
Isradipine—Paraesthesia—Fluorouracil—colon cancer	0.00282	0.00309	CcSEcCtD
Isradipine—CACNA1D—liver—colon cancer	0.00281	0.0412	CbGeAlD
Isradipine—Constipation—Irinotecan—colon cancer	0.0028	0.00307	CcSEcCtD
Isradipine—Angiopathy—Capecitabine—colon cancer	0.0028	0.00307	CcSEcCtD
Isradipine—Dyspnoea—Fluorouracil—colon cancer	0.0028	0.00306	CcSEcCtD
Isradipine—Somnolence—Fluorouracil—colon cancer	0.00279	0.00305	CcSEcCtD
Isradipine—Immune system disorder—Capecitabine—colon cancer	0.00279	0.00305	CcSEcCtD
Isradipine—Mediastinal disorder—Capecitabine—colon cancer	0.00278	0.00305	CcSEcCtD
Isradipine—Dyspepsia—Fluorouracil—colon cancer	0.00276	0.00302	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—colon cancer	0.00275	0.00301	CcSEcCtD
Isradipine—Nifedipine—ABCB1—colon cancer	0.00274	0.147	CrCbGaD
Isradipine—Decreased appetite—Fluorouracil—colon cancer	0.00273	0.00299	CcSEcCtD
Isradipine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00271	0.00297	CcSEcCtD
Isradipine—Mental disorder—Capecitabine—colon cancer	0.0027	0.00296	CcSEcCtD
Isradipine—Nicardipine—ABCB1—colon cancer	0.0027	0.144	CrCbGaD
Isradipine—Feeling abnormal—Irinotecan—colon cancer	0.0027	0.00296	CcSEcCtD
Isradipine—Malnutrition—Capecitabine—colon cancer	0.00269	0.00294	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—colon cancer	0.00264	0.0029	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—colon cancer	0.00262	0.00287	CcSEcCtD
Isradipine—CACNA1H—lymph node—colon cancer	0.00261	0.0383	CbGeAlD
Isradipine—Back pain—Capecitabine—colon cancer	0.0026	0.00285	CcSEcCtD
Isradipine—Feeling abnormal—Fluorouracil—colon cancer	0.00259	0.00283	CcSEcCtD
Isradipine—Muscle spasms—Capecitabine—colon cancer	0.00258	0.00283	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—colon cancer	0.00256	0.0028	CcSEcCtD
Isradipine—Depression—Methotrexate—colon cancer	0.00255	0.00279	CcSEcCtD
Isradipine—Vision blurred—Capecitabine—colon cancer	0.00253	0.00277	CcSEcCtD
Isradipine—Ill-defined disorder—Capecitabine—colon cancer	0.00249	0.00273	CcSEcCtD
Isradipine—Urticaria—Fluorouracil—colon cancer	0.00249	0.00273	CcSEcCtD
Isradipine—Anaemia—Capecitabine—colon cancer	0.00248	0.00272	CcSEcCtD
Isradipine—CACNB2—lymph node—colon cancer	0.00246	0.0361	CbGeAlD
Isradipine—Malaise—Capecitabine—colon cancer	0.00242	0.00265	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—colon cancer	0.00242	0.00265	CcSEcCtD
Isradipine—Asthenia—Vincristine—colon cancer	0.00241	0.00264	CcSEcCtD
Isradipine—Syncope—Capecitabine—colon cancer	0.00241	0.00264	CcSEcCtD
Isradipine—Leukopenia—Capecitabine—colon cancer	0.00241	0.00263	CcSEcCtD
Isradipine—Palpitations—Capecitabine—colon cancer	0.00237	0.0026	CcSEcCtD
Isradipine—Loss of consciousness—Capecitabine—colon cancer	0.00236	0.00259	CcSEcCtD
Isradipine—Asthenia—Irinotecan—colon cancer	0.00235	0.00257	CcSEcCtD
Isradipine—Cough—Capecitabine—colon cancer	0.00234	0.00257	CcSEcCtD
Isradipine—CACNA2D1—lymph node—colon cancer	0.00231	0.0339	CbGeAlD
Isradipine—Diarrhoea—Vincristine—colon cancer	0.0023	0.00252	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—colon cancer	0.0023	0.00252	CcSEcCtD
Isradipine—Chest pain—Capecitabine—colon cancer	0.00229	0.00251	CcSEcCtD
Isradipine—Arthralgia—Capecitabine—colon cancer	0.00229	0.00251	CcSEcCtD
Isradipine—Anxiety—Capecitabine—colon cancer	0.00228	0.0025	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00227	0.00249	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—colon cancer	0.00227	0.00248	CcSEcCtD
Isradipine—Discomfort—Capecitabine—colon cancer	0.00226	0.00247	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—colon cancer	0.00225	0.00247	CcSEcCtD
Isradipine—Diarrhoea—Irinotecan—colon cancer	0.00224	0.00245	CcSEcCtD
Isradipine—Dry mouth—Capecitabine—colon cancer	0.00224	0.00245	CcSEcCtD
Isradipine—Dizziness—Vincristine—colon cancer	0.00222	0.00244	CcSEcCtD
Isradipine—Pruritus—Fluorouracil—colon cancer	0.00222	0.00243	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—colon cancer	0.00221	0.00242	CcSEcCtD
Isradipine—Oedema—Capecitabine—colon cancer	0.00219	0.0024	CcSEcCtD
Isradipine—Dizziness—Irinotecan—colon cancer	0.00217	0.00237	CcSEcCtD
Isradipine—Shock—Capecitabine—colon cancer	0.00216	0.00236	CcSEcCtD
Isradipine—CACNA1D—lymph node—colon cancer	0.00215	0.0316	CbGeAlD
Isradipine—Nervous system disorder—Capecitabine—colon cancer	0.00215	0.00235	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—colon cancer	0.00215	0.00235	CcSEcCtD
Isradipine—Diarrhoea—Fluorouracil—colon cancer	0.00215	0.00235	CcSEcCtD
Isradipine—Thrombocytopenia—Capecitabine—colon cancer	0.00215	0.00235	CcSEcCtD
Isradipine—Tachycardia—Capecitabine—colon cancer	0.00214	0.00234	CcSEcCtD
Isradipine—Vomiting—Vincristine—colon cancer	0.00214	0.00234	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—colon cancer	0.00213	0.00234	CcSEcCtD
Isradipine—Skin disorder—Capecitabine—colon cancer	0.00213	0.00233	CcSEcCtD
Isradipine—Rash—Vincristine—colon cancer	0.00212	0.00232	CcSEcCtD
Isradipine—Hyperhidrosis—Capecitabine—colon cancer	0.00212	0.00232	CcSEcCtD
Isradipine—Dermatitis—Vincristine—colon cancer	0.00212	0.00232	CcSEcCtD
Isradipine—Headache—Vincristine—colon cancer	0.00211	0.00231	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—colon cancer	0.00208	0.00228	CcSEcCtD
Isradipine—Vomiting—Irinotecan—colon cancer	0.00208	0.00228	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—colon cancer	0.00208	0.00227	CcSEcCtD
Isradipine—Dizziness—Fluorouracil—colon cancer	0.00208	0.00227	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—colon cancer	0.00207	0.00227	CcSEcCtD
Isradipine—Rash—Irinotecan—colon cancer	0.00207	0.00226	CcSEcCtD
Isradipine—Dermatitis—Irinotecan—colon cancer	0.00206	0.00226	CcSEcCtD
Isradipine—Headache—Irinotecan—colon cancer	0.00205	0.00225	CcSEcCtD
Isradipine—Hypotension—Capecitabine—colon cancer	0.00205	0.00224	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—colon cancer	0.00201	0.0022	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—colon cancer	0.002	0.00219	CcSEcCtD
Isradipine—Nausea—Vincristine—colon cancer	0.002	0.00219	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.002	0.00219	CcSEcCtD
Isradipine—Vomiting—Fluorouracil—colon cancer	0.002	0.00218	CcSEcCtD
Isradipine—CACNA1C—lymph node—colon cancer	0.00199	0.0292	CbGeAlD
Isradipine—Insomnia—Capecitabine—colon cancer	0.00198	0.00217	CcSEcCtD
Isradipine—Rash—Fluorouracil—colon cancer	0.00198	0.00217	CcSEcCtD
Isradipine—Dermatitis—Fluorouracil—colon cancer	0.00198	0.00216	CcSEcCtD
Isradipine—Paraesthesia—Capecitabine—colon cancer	0.00197	0.00216	CcSEcCtD
Isradipine—Headache—Fluorouracil—colon cancer	0.00197	0.00215	CcSEcCtD
Isradipine—Dyspnoea—Capecitabine—colon cancer	0.00196	0.00214	CcSEcCtD
Isradipine—Nausea—Irinotecan—colon cancer	0.00195	0.00213	CcSEcCtD
Isradipine—Back pain—Methotrexate—colon cancer	0.00193	0.00212	CcSEcCtD
Isradipine—Dyspepsia—Capecitabine—colon cancer	0.00193	0.00211	CcSEcCtD
Isradipine—Decreased appetite—Capecitabine—colon cancer	0.00191	0.00209	CcSEcCtD
Isradipine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00189	0.00207	CcSEcCtD
Isradipine—Fatigue—Capecitabine—colon cancer	0.00189	0.00207	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—colon cancer	0.00189	0.00206	CcSEcCtD
Isradipine—Constipation—Capecitabine—colon cancer	0.00188	0.00205	CcSEcCtD
Isradipine—Nausea—Fluorouracil—colon cancer	0.00186	0.00204	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—colon cancer	0.00186	0.00203	CcSEcCtD
Isradipine—Anaemia—Methotrexate—colon cancer	0.00185	0.00202	CcSEcCtD
Isradipine—Feeling abnormal—Capecitabine—colon cancer	0.00181	0.00198	CcSEcCtD
Isradipine—Malaise—Methotrexate—colon cancer	0.0018	0.00198	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—colon cancer	0.00179	0.00196	CcSEcCtD
Isradipine—Cough—Methotrexate—colon cancer	0.00175	0.00191	CcSEcCtD
Isradipine—Urticaria—Capecitabine—colon cancer	0.00174	0.00191	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—colon cancer	0.0017	0.00186	CcSEcCtD
Isradipine—Chest pain—Methotrexate—colon cancer	0.0017	0.00186	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00169	0.00185	CcSEcCtD
Isradipine—Discomfort—Methotrexate—colon cancer	0.00168	0.00184	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—colon cancer	0.00163	0.00179	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—colon cancer	0.0016	0.00175	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—colon cancer	0.0016	0.00175	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—colon cancer	0.00159	0.00174	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—colon cancer	0.00158	0.00173	CcSEcCtD
Isradipine—Asthenia—Capecitabine—colon cancer	0.00157	0.00172	CcSEcCtD
Isradipine—CYP3A4—renal system—colon cancer	0.00157	0.023	CbGeAlD
Isradipine—Pruritus—Capecitabine—colon cancer	0.00155	0.0017	CcSEcCtD
Isradipine—Hypotension—Methotrexate—colon cancer	0.00153	0.00167	CcSEcCtD
Isradipine—Diarrhoea—Capecitabine—colon cancer	0.0015	0.00164	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00149	0.00163	CcSEcCtD
Isradipine—Insomnia—Methotrexate—colon cancer	0.00148	0.00162	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—colon cancer	0.00147	0.00161	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—colon cancer	0.00146	0.00159	CcSEcCtD
Isradipine—Somnolence—Methotrexate—colon cancer	0.00145	0.00159	CcSEcCtD
Isradipine—Dizziness—Capecitabine—colon cancer	0.00145	0.00159	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—colon cancer	0.00144	0.00157	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—colon cancer	0.00142	0.00155	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00141	0.00154	CcSEcCtD
Isradipine—Fatigue—Methotrexate—colon cancer	0.00141	0.00154	CcSEcCtD
Isradipine—Vomiting—Capecitabine—colon cancer	0.00139	0.00153	CcSEcCtD
Isradipine—Rash—Capecitabine—colon cancer	0.00138	0.00151	CcSEcCtD
Isradipine—Dermatitis—Capecitabine—colon cancer	0.00138	0.00151	CcSEcCtD
Isradipine—Headache—Capecitabine—colon cancer	0.00137	0.0015	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—colon cancer	0.00135	0.00147	CcSEcCtD
Isradipine—Nausea—Capecitabine—colon cancer	0.0013	0.00143	CcSEcCtD
Isradipine—Urticaria—Methotrexate—colon cancer	0.0013	0.00142	CcSEcCtD
Isradipine—CYP3A4—digestive system—colon cancer	0.00128	0.0189	CbGeAlD
Isradipine—Asthenia—Methotrexate—colon cancer	0.00117	0.00128	CcSEcCtD
Isradipine—Pruritus—Methotrexate—colon cancer	0.00115	0.00126	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—colon cancer	0.00112	0.00122	CcSEcCtD
Isradipine—Dizziness—Methotrexate—colon cancer	0.00108	0.00118	CcSEcCtD
Isradipine—Vomiting—Methotrexate—colon cancer	0.00104	0.00114	CcSEcCtD
Isradipine—Rash—Methotrexate—colon cancer	0.00103	0.00113	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—colon cancer	0.00103	0.00113	CcSEcCtD
Isradipine—Headache—Methotrexate—colon cancer	0.00102	0.00112	CcSEcCtD
Isradipine—Nausea—Methotrexate—colon cancer	0.00097	0.00106	CcSEcCtD
Isradipine—CYP3A4—liver—colon cancer	0.000957	0.014	CbGeAlD
